Partilhar
Informação da revista
Original articles
Aortic dilatation after tetralogy of Fallot repair: A ghost from the past or a problem in the future?
Cristina Cruz, Teresa Pinho, Vânia Ribeiro, Cláudia Camila Dias, José Silva Cardoso, Maria Júlia Maciel
Rev Port Cardiol. 2018;37:549-57
Open access
Original Articles
Editorial comment
Aortic dilatation in repaired tetralogy of Fallot: Can an old problem be solved?
Fátima F. Pinto
Rev Port Cardiol. 2018;37:559-61
Open access
Portuguese Registry of Acute Coronary Syndromes (ProACS): 15 years of a continuous and prospective registry
Ana Teresa Timóteo, Jorge Mimoso
Rev Port Cardiol. 2018;37:563-73
Open access
Original Articles
Editorial comment
Confirming the value of continuous registries of clinical activity
R. Seabra Gomes
Rev Port Cardiol. 2018;37:575-6
Open access
Assessment of cardiovascular risk and social framework of Cape Verdean university students studying in Portugal
Liliana Tavares, Conceição Calhau, Jorge Polónia
Rev Port Cardiol. 2018;37:577-82
Open access
Original Articles
Editorial comment
The phenomenon of migration and cardiovascular risk factors
Manuel Campelo
Rev Port Cardiol. 2018;37:583-4
Open access
Comparison of multiparametric risk scores for predicting early mortality after transcatheter aortic valve implantation
João Carmo, Rui Campante Teles, Sérgio Madeira, António Ferreira, João Brito, Tiago Nolasco, Pedro de Araújo Gonçalves, Henrique Mesquita Gabriel, ... Miguel Mendes
Rev Port Cardiol. 2018;37:585-90
Open access
Original Articles
Editorial comment
Risk scores: Are these tools imperfect, or merely complex to use?
Henrique Cyrne Carvalho
Rev Port Cardiol. 2018;37:591-3
Open access
Worsening or ‘pseudo-worsening’ renal function? The prognostic value of hemoconcentration in patients admitted with acute heart failure
José Luís Martins, Luís Santos, Ana Faustino, Jesus Viana, José Santos
Rev Port Cardiol. 2018;37:595-602
Open access
Original Articles
Editorial comment
Putting creatinine and hemoconcentration in their place as prognostic predictors in the conundrum of acute heart failure
Pedro Marques da Silva
Rev Port Cardiol. 2018;37:603-5
Open access
Review article
Cardiovascular risk in Turner syndrome
Beatriz Donato, Maria João Ferreira
Rev Port Cardiol. 2018;37:607-21
Open access
Case reports
The role of Impella in high-risk percutaneous coronary intervention
Sara Moura-Ferreira, Ricardo Ladeiras-Lopes, Domingas MBala, Alberto Rodrigues, Pedro Braga, Vasco Gama
Rev Port Cardiol. 2018;37:623.e1-4
Open access
Should first blood pressure measurement be performed in the newborn?
Inês Alves, Tânia Martins, Ana Luísa Neves, Esmeralda Rodrigues, Ana Teixeira, Caldas Afonso, Helena Pinto
Rev Port Cardiol. 2018;37:625.e1-5
Open access
Images in cardiology
Persistent left superior vena cava – A vascular access without limitations
Tatiana Guimarães, Ana Bernardes, João de Sousa, Pedro Marques
Rev Port Cardiol. 2018;37:627-8
Open access
Right ventricle enlargement: A diagnosis beyond the heart?
Beatriz S. Santos, Paulo Donato, Cátia Costa, David Durão, Isabel Monteiro, Maria João Ferreira
Rev Port Cardiol. 2018;37:629-30
Open access
Letters to the editor
Residual shunt due to spontaneous perforation of polyvinyl alcohol membrane of ASD Occluder; what about after diagnosis?
Serdar Bozyelç, Tayfun Sahin
Rev Port Cardiol. 2018;37:631
Open access
Reply to the Letter to the Editor “Residual shunt due to spontaneous perforation of polyvinyl alcohol membrane of ASD Occluder. What about after diagnosis?”
Sílvia Aguiar Rosa
Rev Port Cardiol. 2018;37:633
Open access
Recommended article of the month
Brief Comment Video to the Recommended Article of the Month
Rev Port Cardiol. 2018;37:635
Open access
Conteúdo especial sobre COVID-19
- High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal
- Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitus
- Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?
- RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.